Dana-Farber Cancer Institue is a clinical research site located in Boston, Massachusetts, United States 02115.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Dana-Farber Cancer Institue has participated in 1 clinical trials.
Therapeutic areas: Solid Tumor, Liver Metastases.
Sponsors: Massachusetts General Hospital.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana-Farber Cancer Institue has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana-Farber Cancer Institue has 1 clinical trials on record. Their work covers Solid Tumor, Liver Metastases.
Dana-Farber Cancer Institue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.